The robustness and the generality of the methodology is tested on controlled YAP-TEAD Inhibitor 1 chemical structure simulations, reporting a good agreement between theoretically expected and identified values. The assumptions behind the underlying theoretical framework make the method
readily applicable to biological preparations like culture neuron networks and in vitro brain slices.”
“Copper-iron spinel (CuFe2O4) in cubic phase was prepared via a simple citrate sol-gel method and was, transformed into tetragonal phase of high crystallinity by calcining in air at 900 degrees C. Composites of CuFe2O4 spinel and gamma-Al2O3 were investigated for catalytic production of hydrogen from dimethyl ether steam reforming (DME SR). X-ray photoelectron spectroscopy showed Cu1+-rich surface species (Cu1+/Cu-0 approximate to ca. 3/2 with negligible Cu2+) over
the calcined CuFe2O4 subjected to in situ H-2 reduction. The spinel-oxides with lower content of reducible Cu species possessed higher amount of Cu1+ species under the reducing atmosphere, corresponding selleck kinase inhibitor to higher DME SR activity. Copper clusters highly dispersed in the matrix of iron oxides were reduced from the spinel structure, and the strong interaction between them should result in the high activity and durability. The degraded catalysts after DME SR were regenerated by calcining in air in the temperature range of 350-800 degrees C. Slow deactivation of the composites observed during DME SR at 375 degrees C was mainly attributable to non-graphitic carbonaceous species deposited on the catalyst surface. (C) 2009 Elsevier B.V. All rights reserved.”
“Background: Prior studies have shown age-related macular degeneration (AMD) to be associated Angiogenesis inhibitor with falls. The purpose of this study is to determine if (AMD) and AMD-related vision
loss are associated with fear of falling, an important and distinct outcome. Methods: Sixty-five persons with AMD with evidence of vision loss in one or both eyes and 60 glaucoma suspects with normal vision completed the University of Illinois at Chicago Fear of Falling questionnaire. Responses were Rasch analyzed. Scores were expressed in logit units, with lower scores demonstrating lesser ability and greater fear of falling. Results: Compared to glaucoma suspect controls, AMD subjects had worse visual acuity (VA) (median better-eye VA = 20/48 vs. 20/24, p smaller than 0.001) and worse contrast sensitivity (CS) (binocular CS = 1.9 vs. 1.5 log units, p smaller than 0.001). AMD subjects were also older, more likely to be Caucasian, and less likely to be employed (p smaller than 0.05 for all), but were similar with regards to other demographic and health measures. In multivariable models controlling for age, gender, body habitus, strength, and comorbid illnesses, AMD subjects reported greater fear of falling as compared to controls (beta = -0.77 logits, 95% CI = -1.5 to -0.002, p = 0.045). In separate multivariable models, fear of falling increased with worse VA (beta = -0.